Financial Performance - Revenue for Q2 of fiscal year 2026 was $20.3 million, down from $41.8 million in Q2 of fiscal year 2025, reflecting a strategic shift to reduce low-quality cannabis customers [1][4] - Gross profit was $3.5 million, compared to $7.7 million in the same quarter last year, with a gross margin of 17.1%, down from 18.5% [1][4] - Total operating expenses decreased to $10.3 million from $15.1 million year-over-year, indicating effective cost control measures [1][4] - Net loss for the quarter was $6.6 million, or $0.12 per share, an improvement from a net loss of $8 million, or $0.14 per share, in the previous year [1][5] Strategic Initiatives - The company is focusing on high-quality revenue acquisition and has successfully reduced net accounts receivable by 19.5% to $37.9 million from $47 million at the end of fiscal year 2025 [2][4] - Ispire is enhancing production capacity in Malaysia in preparation for a full-scale expansion in fiscal year 2026 [2] - The company is actively pursuing licensing and collaboration opportunities with major and mid-sized nicotine product manufacturers for its proprietary G-Mesh technology [2] Regulatory Environment - The company supports the U.S. federal government's efforts to enforce regulations against illegal sales of flavored e-cigarettes, emphasizing the need for a legitimate market authorized by the FDA [3] - Ispire and its joint venture, IKE, are positioned as key players in establishing a legal market for flavored e-cigarettes, leveraging technology to prevent underage access and ensure product authenticity [3]
雾麻科技(ISPR.US)发布2026财年第二季度财务业绩:自2025年6月30日以来 持续推进的应收账款催收工作使净应收账款减少了19% 截至2025...